147 related articles for article (PubMed ID: 32524651)
1. Acral fibromyxoma with loss of Rb1 by immunohistochemistry and fluorescence in situ hybridization: A diagnostically exploitable marker.
Motanagh S; Bridge JA; Linos K
J Cutan Pathol; 2021 Feb; 48(2):295-301. PubMed ID: 32524651
[TBL] [Abstract][Full Text] [Related]
2. Superficial acral fibromyxoma: clinicopathological, immunohistochemical, and molecular study of 11 cases highlighting frequent Rb1 loss/deletions.
Agaimy A; Michal M; Giedl J; Hadravsky L; Michal M
Hum Pathol; 2017 Feb; 60():192-198. PubMed ID: 27825811
[TBL] [Abstract][Full Text] [Related]
3. Onychomatricoma: a clinicopathological, immunohistochemical, and molecular study of 10 cases highlighting recurrent RB1 deletion and the potential diagnostic value of LEF-1.
Perrin C; Pedeutour F; Coutts M; Ambrosetti D; Dadone-Montaudié B
Histopathology; 2023 Apr; 82(5):767-778. PubMed ID: 36647795
[TBL] [Abstract][Full Text] [Related]
4. Loss of retinoblastoma in pleomorphic fibroma: An immunohistochemical and genomic analysis.
Hinds B; Agulló Pérez AD; LeBoit PE; McCalmont TH; North JP
J Cutan Pathol; 2017 Aug; 44(8):665-671. PubMed ID: 28543636
[TBL] [Abstract][Full Text] [Related]
5. Onychomatricoma is not a subtype of superficial acral fibromyxoma: Can immunohistochemistry help in the differential diagnosis?
Perrin C; Coutts M
J Cutan Pathol; 2024 Jun; 51(6):439-440. PubMed ID: 38527773
[No Abstract] [Full Text] [Related]
6. RB1 loss in the mesenchymal component of onychomatricoma.
Liu Y; Zou D; Huang Q; Wang L
J Cutan Pathol; 2023 Dec; 50(12):1094-1098. PubMed ID: 37596842
[TBL] [Abstract][Full Text] [Related]
7. Fibroepithelial Stromal Polyp of the Vulvovaginal Region as Part of the RB1 Family of Tumors: Friend or Foe?
Cordier F; Van Roy N; Matthys B; De Paepe P; Van de Vijver K; Van Dorpe J; Creytens D
Int J Gynecol Pathol; 2024 May; 43(3):215-220. PubMed ID: 37922949
[TBL] [Abstract][Full Text] [Related]
8. Digital fibromyxoma (superficial acral fibromyxoma): a detailed characterization of 124 cases.
Hollmann TJ; Bovée JV; Fletcher CD
Am J Surg Pathol; 2012 Jun; 36(6):789-98. PubMed ID: 22367301
[TBL] [Abstract][Full Text] [Related]
9. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
10. Cellular digital fibromas: what about superficial acral fibromyxoma?
Guitart J; Ramirez J; Laskin WB
J Cutan Pathol; 2006 Nov; 33(11):762-3; author reply 764. PubMed ID: 17083699
[No Abstract] [Full Text] [Related]
11. Benign Fibromyxoid Lesion of the Breast: A Distinct Entity From Benign Spindle Cell Tumors of the Mammary Stroma?
Schwartz CJ; Schandl CA; Morse J; Ralston J; Rapkiewicz A; Darvishian F
Int J Surg Pathol; 2018 Sep; 26(6):488-493. PubMed ID: 29552929
[TBL] [Abstract][Full Text] [Related]
12. Superficial acral fibromyxoma and other slow-growing tumors in acral areas.
Schwager ZA; Mannava KA; Mannava S; Telang GH; Robinson-Bostom L; Jellinek NJ
Cutis; 2015 Feb; 95(2):E15-9. PubMed ID: 25750972
[TBL] [Abstract][Full Text] [Related]
13. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
[TBL] [Abstract][Full Text] [Related]
14. Superficial acral fibromyxoma.
Sawaya JL; Khachemoune A
Int J Dermatol; 2015; 54(5):499-508. PubMed ID: 25772615
[TBL] [Abstract][Full Text] [Related]
15. The
Berry JL; Polski A; Cavenee WK; Dryja TP; Murphree AL; Gallie BL
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31683923
[TBL] [Abstract][Full Text] [Related]
16. RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors.
Kohlmeyer JL; Kaemmer CA; Pulliam C; Maharjan CK; Samayoa AM; Major HJ; Cornick KE; Knepper-Adrian V; Khanna R; Sieren JC; Leidinger MR; Meyerholz DK; Zamba KD; Weimer JM; Dodd RD; Darbro BW; Tanas MR; Quelle DE
Clin Cancer Res; 2020 Jun; 26(12):2997-3011. PubMed ID: 32086342
[TBL] [Abstract][Full Text] [Related]
17. [Superficial acral fibromyxoma in a sub-matricial location: An unusual variant].
Chabbab F; Metz T; Saez Beltran L; Theunis A; Richert B
Ann Dermatol Venereol; 2014 Feb; 141(2):94-105. PubMed ID: 24507203
[TBL] [Abstract][Full Text] [Related]
18. RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer.
Nava Rodrigues D; Casiraghi N; Romanel A; Crespo M; Miranda S; Rescigno P; Figueiredo I; Riisnaes R; Carreira S; Sumanasuriya S; Gasperini P; Sharp A; Mateo J; Makay A; McNair C; Schiewer M; Knudsen K; Boysen G; Demichelis F; de Bono JS
Clin Cancer Res; 2019 Jan; 25(2):687-697. PubMed ID: 30257982
[TBL] [Abstract][Full Text] [Related]
19. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
20. Superficial acral fibromyxoma: a CD34+ periungual tumor.
Messeguer F; Nagore E; Agustí-Mejias A; Traves V
Actas Dermosifiliogr; 2012 Jan; 103(1):67-9. PubMed ID: 22445566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
